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(Claron Technology Inc., Canada) positioned on either side
of the PET scanner (Kyme et al, 2011) while the animal
moves freely within the chamber. Pose data are used to
smoothly adjust the position of the chamber within the
PET FoV (Zhou et al., 2013) and to correct coincidence
events for motion within a list mode MLEM reconstruction
algorithm (Rahmim et al., 2008).
Two adult male Sprague-Dawley rats were administered
45MBq (<1 nmol) [11C]raclopride via an indwelling jugular
vein catheter and imaged in the Open Field system for
50min. One animal was administered 2 mg.kg1 of unla-
belled raclopride (D2 antagonist) and the other animal 1
mg.kg1 of sumanirole (full D2 agonist) 20 minutes after
tracer injection. Dynamic PET data were analysed by least
squares fitting striatal and cerebellar time-activity curves
with the lp-ntPET ligand displacement model (Normandin
et al., 2012). The posterior probability distributions of
displacement parameters were further analysed using an
Automated Bayesian Computation rejection algorithm
(Marin et al., 2011). Behavioral data were analysed by mea-
suring absolute head displacement as a proxy for locomo-
tor activity before and after drug injection and compared
with the timing and magnitude of [11C]raclopride
displacement.
Results:
Both drugs caused a measurable displacement of
[11C]raclopride which corresponded to their injection
times, i.e. approximately 20min (figure 1). In the case of
sumanirole the displacement also correlated with
increased locomotor activity (492%), consistent with ago-
nist effects on the indirect thalamo-striatal dopaminergic
pathway. The displacement was similar in magnitude (k2a(t)
= 1.5-2x baseline) for the two studies but more prolonged
in the case of raclopride than sumanirole.
Conclusions:
The Open Field PET technique thus allows simultaneous
measurements of PET derived changes in regional receptor
binding and behavioral responses due to controlled stimuli
in conscious unrestrained animals.
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Abstract
Introduction: Dopamine receptor was down regulated in
obese animals and humans brain (Nummennmaa et al,
2012). Data are conflicting about the density of dopamine
transporter in obese striatum. Furthermore, while striatal
D2R availability is negatively associated with frontocortical
glucose metabolism in obese patient (Volkow et al, 2004),
the impact of obesity on striatal metabolism is unknown.
Methods: Fourteen adults mini-pigs were imaged for dopa-
mine transporter and glucose metabolism in lean and
obese conditions. Obesity was induced by high fat, high
glucose diet supplied at 200% metabolic requirement
(measured by indirect calorimetry) during 3 months.
Brain glucose metabolism was obtained using PET imaging
(HR+ Siemens) after the IV injection of 250 MBq FDG
(IBA). The density of dopamine transporter was evaluated
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using SPECT imaging (Millenium, GE) after the IV injection
of 180 MBq DatScan (GE). Sinograms were corrected for
attenuation using STIR software. FDG images were core-
gistered against a PET template (n=20 animals) obtained
using the same machine and identical pig breed in our
laboratory. DATScan images were also coregistered using
a DATscan template (n=10 animals). Both templates were
within the same tridimensionnal reference i.e. a pig brain
atlas consisting in 70 paired structures and 30 unpaired
ones (Saikali et al, 2010). Coregistration was achieved
using FNIRT from FSL software. The amount of radioac-
tivity in specific areas was obtained using Pmod software
adapted to our pig brain atlas with SVC applied. Data afte
normalisation were also analysed without apriori using
SPM8 software.
Results: The animals almost doubled their weight during
the three months high calorie, high fat/glucose diet (87 
4.4 versus 36  3.9 Kg). Striatal dopamine transporter
density expressed as the ratio between striatum vs occi-
pital cortex was significantly less in the obese than in lean
situation (1.8  0.04 vs 1.6  0.02, p<0.01). Inversely, the
striatal glucose metabolism expressed as the ratio
between striatum vs cerebellum was significantly greater
in the obese than in the lean condition (1.4  0.02 vs 2.3 
0.02, p<0.01). Identical figures were obtained with statis-
tical parameter mapping analyses.
Conclusions: Our results demonstrated clearly a reduced
density of striatal dopamine transporter in morbid obese
animal. This was associated with an increased striatal
metabolism that might compensate for changes in synaptic
dopamine availability. This uncoupling might a critical
mechanism to explain overeating in obesity.
Figure 1 - Statistical image showing the decreased dopa-
mine transporter density in obese compared to lean
condition (shades of blues mean that the radioactivty is
less in obese than in lean condition whereas shades of
red mean that the radioactivity is more in obese than in
lean condition) at the striatal level. The striatum is high-
lighted in white underlined with orange line for compre-
hension. It is visible arround the most intense blue spot
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Abstract
Objectives
Increased expression of 18kDa translocator protein
(TSPO) by activated glia in the CNS has been reported
in various neuroinflammatory conditions1,2. Positron emis-
sion tomography (PET) with the new generation TSPO
radioligands may provide a sensitive and non-invasive
approach for quantifying inflammatory processes in vivo.
Myelin oligodendrocyte glycoprotein (MOG)-induced
experimental autoimmume encephalomyelitis (EAE) is an
established preclinical model of multiple sclerosis. We
investigated whether the change in TSPO availability
induced in the EAE model can be detected in vivo using
the TSPO ligand [11C]PBR28.
Methods
All procedures were carried out in accordance with the
UK Home Office Animal (Scientific Procedures) Acts
1986. Recombinant MOG corresponding to the N-term-
inal extracellular domain of mouse (rmMOG,1–116a.a.)
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